Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions

Applied Microbiology and Biotechnology

Volumn 56, Issue 1-2, 2001, Pages 150-156

  Liu, Y ^a   Frazer, I H ^a   Liu, W J ^a   Liu, X S ^a   McMillan, N ^a   Zhao, K N ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

DNA;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; GENE DELETION; GENE TARGETING; GENETIC TRANSFECTION; NONHUMAN; PAPILLOMA VIRUS; REPORTER GENE; VIRION; VIRUS ASSEMBLY; VIRUS CULTURE; VIRUS GENOME; VIRUS PARTICLE; VIRUS PURIFICATION;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; CAPSID; CAPSID PROTEINS; COS CELLS; DNA; VIRION; VIRUS ASSEMBLY;

EID: 0034918519     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002530100655     Document Type: Article

References (35)

1. High mutation frequency in DNA transfected into mammalian cells
2. Formation of deletions after initiation of simian virus 40 replication: Influence of packaging limit of the capsid
3. The simian virus 40 packaging signal ses is composed of redundant DNA elements which are partly interchangeable
4. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains
5. A first-generation packaging cell line for Epstein-Barr virus-derived vectors
6. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures
7. A quantitative in vitro focus assay for bovine papilloma virus
8. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
9. Phage DNA packaging
10. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
11. Capsid assembly and DNA packaging in herpes simplex virus
12. Role of the human papillomaviruses in human cancer
13. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes
14. In vitro construction of pseudovirions of human papillomavirus type 16: Incorporation of plasmid DNA into reassembled L1/L2 capsids
15. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
16. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
17. Transfected DNA is mutated in monkey, mouse, and human cells
18. Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro
19. Expression of the a6 integrin confers papillomavirus binding upon receptor-negative B-cells
20. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation
21. Helpers for efficient encapsidation of SV40 pseudovirions
22. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype
23. In vitro assembly of SV40 virions and pseudovirions: Vector development for gene therapy
24. Infectious human papillomavirus type 18 pseudovirions
25. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
26. In vitro gene transfer using human papillomavirus-like particles
27. Generation and neutralization of pseudovirions of human papillomavirus type 33
28. Examination of conditions affecting the efficiency of HVS-1 amplicon packaging
29. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1
30. Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids
31. BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions
32. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles
33. Synthesis and assembly of infectious bovine papillomavirus particles in vitro
34. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence
35. Papillomavirus infections - A major cause of human cancers